Clinical trial Recruiting at 1 site Interventional Ages 18 to 44 Women only

Single-layer versus double-layer uterine closure after cesarean and myometrial thickness

Official title: Effects of Single-Layer Versus Double-Layer Cesarean Scar Repair on Myometrial Thickness and Associated Clinical Outcomes

Run by Ankara City Hospital Bilkent · NCT07323355 · Data updated 2026-11-12

This trial tests whether closing the uterus with one layer or two layers during cesarean leads to thicker, healthier scar tissue in women having a cesarean delivery.

Quick facts

Study typeInterventional
Ages18 Years to 44 Years
SexWomen only
Enrollment102 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, Not Valid)
StatusRecruiting
StartedNovember 11, 2025
Main results expectedSeptember 21, 2026
Study endsNovember 15, 2026
Registry record updatedJanuary 7, 2026
Trial IDNCT07323355 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–44 who are delivering by cesarean at the study hospital, are clinically healthy on routine preoperative tests, and meet the listed inclusion criteria.

Probably not a fit

Women with chronic illnesses, suspected or confirmed placenta previa/accreta, anterior wall myomas, nonstandard uterine incisions, predicted obstetric hemorrhage, or those who will not deliver at the study site are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares single-layer and double-layer uterine closure techniques in women undergoing cesarean delivery at Ankara Bilkent City Hospital. Eligible participants receive one of the two closure methods during their cesarean operation and are followed after surgery. Myometrial thickness and scar characteristics will be measured using postoperative ultrasound and clinical follow-up. The protocol excludes women with chronic systemic disease, placenta previa/accreta, anterior uterine fibroids, nonstandard uterine incisions, or predicted obstetric hemorrhage.

Why it matters

Potential benefit: If one closure method produces reliably thicker myometrium and fewer scar defects, it could reduce postmenstrual symptoms and lower the risk of serious future complications like uterine rupture or placenta accreta.

How similar studies have gone: Previous comparisons of single- versus double-layer uterine closure have shown mixed results and there is no clear consensus on which technique best prevents scar defects.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female participants aged 18-44 years.
* Undergoing cesarean delivery at the study hospital's Obstetrics and Gynecology clinic.
* Evaluated as clinically eligible based on history, physical examination, abdominal ultrasonography, and routine preoperative laboratory tests, including:

Complete blood count (CBC), biochemical profile, prothrombin time (PT), activated partial thromboplastin time (aPTT), blood group determination. No abnormalities detected in the above assessments.

Exclusion Criteria:

\- Presence of chronic diseases, including: Rheumatologic diseases, renal failure, vascular malformations, hypertension, cardiac disease, diabetes mellitus, obesity, thyroid disease, congenital hematologic disorders.

* Suspected or confirmed placenta previa or placenta accreta spectrum.
* Clinical chorioamnionitis.
* Anterior wall uterine myomas.
* History of low transverse nonstandard uterine incision.
* Predicted obstetric hemorrhage or other intraoperative complications.

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Not Valid, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Merve Didem Eşkin Tanrıverdi — Ankara City Hospital Bilkent
  • Study coordinator: Merve Didem Eşkin Tanrıverdi, MD
  • Email: mrvddm@hotmail.com
  • Phone: +905354071467

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.